Avricore Health (AVCRF) Accounts Payables (2009 - 2025)

Avricore Health has disclosed Accounts Payables across 17 years of filings, most recently posting $124458.2 for Q4 2025.

• In Q4 2025, Accounts Payables fell 47.44% year-over-year to $124458.2; the TTM figure through Dec 2025 stood at $124458.2 (down 47.44% YoY), while the FY2025 annual figure was $124221.3, down 48.59% from the prior year.
• Accounts Payables grew to $124458.2 in Q4 2025, from $26075.3 in the prior quarter.
• Over the last five years, Accounts Payables for AVCRF reached as high as $452405.3 in Q3 2023 and fell as low as $20904.5 in Q1 2022.
• The 5-year median for Accounts Payables is $164464.6 (2021), against an average of $192570.3.
• Annual changes were most pronounced in 2023 — Accounts Payables surged 1203.87% — and 2025, when it sank 93.36%.
• A 5-year view of Accounts Payables shows it stood at $35285.2 in 2021, then soared by 445.96% to $192642.7 in 2022, then soared by 63.45% to $314878.5 in 2023, then decreased by 24.79% to $236815.1 in 2024, then plunged by 47.44% to $124458.2 in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $124458.2, $26075.3, and $33592.8 for Q4 2025, Q3 2025, and Q2 2025 respectively.